Patents by Inventor Susanne Scheele

Susanne Scheele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID GLP-1 DERIVATIVE COMPOSITIONS FOR ORAL ADMINISTRATION
    Publication number: 20220016216
    Abstract: The present invention relates to solid compositions for oral administration comprising (i) a GLP-1 derivative and the SGLT2 inhibitor dapagliflozin or (ii) a GLP-1 derivative and a salt of NAC in combination with an SGLT2 inhibitor.
    Type: Application
    Filed: October 8, 2021
    Publication date: January 20, 2022
    Inventors: Andreas Vegge, Susanne Scheele, Simon Bjerregaard
  • Solid glp-1 derivative compositions for oral administration
    Patent number: 11167014
    Abstract: The present invention relates to solid compositions for oral administration comprising (i) a GLP-1 derivative and the SGLT2 inhibitor dapagliflozin or (ii) a GLP-1 derivative and a salt of NAC in combination with an SGLT2 inhibitor.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: November 9, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Andreas Vegge, Susanne Scheele, Simon Bjerregaard
  • SOLID COMPOSITIONS FOR ORAL ADMINISTRATION
    Publication number: 20200147179
    Abstract: The present invention relates to solid compositions for oral administration comprising (i) a GLP-1 derivative and the SGLT2 inhibitor dapagliflozin or (ii) a GLP-1 derivative and a salt of NAC in combination with an SGLT2 inhibitor.
    Type: Application
    Filed: June 11, 2018
    Publication date: May 14, 2020
    Inventors: Andreas Vegge, Susanne Scheele, Simon Bjerregaard